Zobrazeno 1 - 10
of 853
pro vyhledávání: '"Joseph H, Antin"'
Autor:
Mary Eapen, Joseph H. Antin, Jakub Tolar, Sally Arai, Mitchell E. Horwitz, Jianqun Kou, Eric Leifer, John M. McCarty, Ryotaro Nakamura, Michael A. Pulsipher, Scott D. Rowley, Mary M. Horowitz, H Joachim Deeg
Publikováno v:
EClinicalMedicine, Vol 76, Iss , Pp 102819- (2024)
Summary: Background: Almost all acquired severe aplastic anaemia is immune mediated and characterised by hypocellular bone marrow and ≥2 affected haematopoietic lineages. The optimal preparartive regimen for unrelated donor transplantation remains
Externí odkaz:
https://doaj.org/article/727f09c81ccf402580493c5681107953
Autor:
Katie Maurer, Joseph H. Antin
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for many hematologic malignancies as well as non-malignant conditions. Part of the curative basis underlying HSCT for hematologic malignancies relies upon ind
Externí odkaz:
https://doaj.org/article/76ab829b39e94e9b922ff43535853bda
Autor:
Neha Gupta, MPH, Cesar A. Virgen, MD, PhD, Amrita Goyal, MD, Andrew A. Lane, MD, PhD, Joseph H. Antin, MD, Sherrie J. Divito, MD, PhD, Cecilia Larocca, MD
Publikováno v:
JAAD Case Reports, Vol 33, Iss , Pp 67-69 (2023)
Externí odkaz:
https://doaj.org/article/8eff8acd2dc94259ab03c75a1d4d7d9f
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundFifty years of hematopoietic cell transplantation (HCT) has ushered in an exciting era of cellular therapy and has led to enormous progress in improving the outcomes of patients with both malignant and non-malignant hematologic disease. As
Externí odkaz:
https://doaj.org/article/397ee73f40894cfba379af2fcb719b23
Autor:
Roman M. Shapiro, Grace C. Birch, Guangan Hu, Juliana Vergara Cadavid, Sarah Nikiforow, Joanna Baginska, Alaa K. Ali, Mubin Tarannum, Michal Sheffer, Yasmin Z. Abdulhamid, Benedetta Rambaldi, Yohei Arihara, Carol Reynolds, Max S. Halpern, Scott J. Rodig, Nicole Cullen, Jacquelyn O. Wolff, Kathleen L. Pfaff, Andrew A. Lane, R. Coleman Lindsley, Corey S. Cutler, Joseph H. Antin, Vincent T. Ho, John Koreth, Mahasweta Gooptu, Haesook T. Kim, Karl-Johan Malmberg, Catherine J. Wu, Jianzhu Chen, Robert J. Soiffer, Jerome Ritz, Rizwan Romee
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 11 (2022)
Background Responses to conventional donor lymphocyte infusion for postallogeneic hematopoietic cell transplantation (HCT) relapse are typically poor. Natural killer (NK) cell–based therapy is a promising modality to treat post-HCT relapse.Methods
Externí odkaz:
https://doaj.org/article/2699fa01730746f2b44f722f69c72b21
Autor:
Benedetta Rambaldi, Haesook T. Kim, Yohei Arihara, Takeru Asano, Carol Reynolds, Mariah Manter, Max Halpern, Augustine Weber, John Koreth, Corey Cutler, Mahasweta Gooptu, Sarah Nikiforow, Vincent T. Ho, Joseph H. Antin, Rizwan Romee, Jeanette Ampudia, Cherie Ng, Stephen Connelly, Robert J. Soiffer, Jerome Ritz
Publikováno v:
Haematologica, Vol 107, Iss 11 (2022)
CD6 is a co-stimulatory receptor expressed on T cells that binds activated leukocyte cell adhesion molecule (ALCAM), expressed on antigen presenting cells, epithelial and endothelial tissues. The CD6-ALCAM pathway plays an integral role in modulating
Externí odkaz:
https://doaj.org/article/028cbeb056154b0f986dae1e00d73c08
Autor:
Katie Maurer, Haesook T. Kim, Heather M. Garrity, Deborah Liney, Corey Cutler, Joseph H. Antin, John Koreth, Jerome Ritz, Roman M. Shapiro, Rizwan Romee, Vincent T. Ho, Mahasweta Gooptu, Robert J. Soiffer, Catherine J. Wu, Sarah Nikiforow
Publikováno v:
Blood Advances. 7:2431-2435
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd3449a6b60cdeb55921d8157979bcbd
https://doi.org/10.1182/bloodadvances.2022009231
https://doi.org/10.1182/bloodadvances.2022009231
Autor:
Haesook T. Kim, Peter O. Baker, Erin Parry, Matthew Davids, Edwin P. Alyea, Vincent T. Ho, Corey Cutler, John Koreth, Mahasweta Gooptu, Rizwan Romee, Sarah Nikiforow, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer, Catherine J. Wu, Jennifer R. Brown
Publikováno v:
Haematologica, Vol 106, Iss 12 (2021)
Externí odkaz:
https://doaj.org/article/7dd653f984984ac8967ac5f65f2ffb3c
Autor:
Nelli Bejanyan, Soyoung Kim, Kyle M. Hebert, Natasha Kekre, Hisham Abdel-Azim, Ibrahim Ahmed, Mahmoud Aljurf, Sherif M. Badawy, Amer Beitinjaneh, Jaap Jan Boelens, Miguel Angel Diaz, Christopher C. Dvorak, Shahinaz Gadalla, James Gajewski, Robert Peter Gale, Siddhartha Ganguly, Andrew R. Gennery, Biju George, Usama Gergis, David Gómez-Almaguer, Marta Gonzalez Vicent, Hasan Hashem, Rammurti T. Kamble, Kimberly A. Kasow, Hillard M. Lazarus, Vikram Mathews, Paul J. Orchard, Michael Pulsipher, Olle Ringden, Kirk Schultz, Pierre Teira, Ann E. Woolfrey, Blachy Dávila Saldaña, Bipin Savani, Jacek Winiarski, Jean Yared, Daniel J. Weisdorf, Joseph H. Antin, Mary Eapen
Publikováno v:
Blood Advances, Vol 3, Iss 20, Pp 3123-3131 (2019)
Abstract: Allogeneic bone marrow transplantation (BMT) is curative therapy for the treatment of patients with severe aplastic anemia (SAA). However, several conditioning regimens can be used for BMT. We evaluated transplant conditioning regimens for
Externí odkaz:
https://doaj.org/article/5355366127ff44c8b0ec931af3a7f734
Autor:
Jennifer S. Whangbo, Haesook T. Kim, Nikola Mirkovic, Lauren Leonard, Samuel Poryanda, Sophie Silverstein, Soomin Kim, Carol G. Reynolds, Sharmila C. Rai, Kelly Verrill, Michelle A. Lee, Steven Margossian, Christine Duncan, Leslie Lehmann, Jennifer Huang, Sarah Nikiforow, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Bruce R. Blazar, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, John Koreth
Publikováno v:
Blood Advances, Vol 3, Iss 17, Pp 2550-2561 (2019)
Abstract: Low-dose interleukin-2 (IL-2) therapy for chronic graft-versus-host disease (cGVHD) generates a rapid rise in plasma IL-2 levels and CD4+CD25+CD127−Foxp3+ regulatory T-cell (CD4Treg) proliferation, but both decrease over time despite cont
Externí odkaz:
https://doaj.org/article/7451b006929a41fca3f95f87e7835ef3